A recent study highlights the lethal combination of p.V142I variant transthyretin amyloid cardiomyopathy and complex congenital heart disease. This research underscores the need for further investigation into the implications of this genetic variant in affected patients.
p v142i associated variant transthyretin amyloid cardiomyopathy complicating complex congenital heart disease a lethal combination
Original title: “p.(V142I)-Associated Variant Transthyretin Amyloid Cardiomyopathy Complicating Complex Congenital Heart Disease: A Lethal Combination.”